Display options
Share it on

Adv Neonatal Care. 2021 Dec 01;21(6):452-461. doi: 10.1097/ANC.0000000000000959.

Vagal Tone and Proinflammatory Cytokines Predict Feeding Intolerance and Necrotizing Enterocolitis Risk.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses

Alissa L Meister, Fumiyuki C Gardner, Kirsteen N Browning, R Alberto Travagli, Charles Palmer, Kim Kopenhaver Doheny

Affiliations

  1. Department of Neural and Behavioral Sciences (Drs Meister, Browning, Travagli, and Doheny), and Division of Neonatal-Perinatal Medicine, Department of Pediatrics (Drs Gardner, Palmer and Doheny), College of Medicine, The Pennsylvania State University, Hershey.

PMID: 34847103 PMCID: PMC8638911 DOI: 10.1097/ANC.0000000000000959

Abstract

BACKGROUND: Necrotizing enterocolitis (NEC) is the leading cause of death due to gastrointestinal disease in preterm neonates; yet, clinicians lack reliable and noninvasive predictive tools.

PURPOSE: We aimed to test that diminished high-frequency heart rate variability (HF-HRV) and elevated levels of proinflammatory cytokines would have utility in NEC prediction.

METHODS: In this multisite prospective study, we enrolled 250 preterm (26-34 weeks' postmenstrual age [PMA]) neonates with physiological stability at 72 hours of life. HRV was measured noninvasively using electrocardiograhic data from standardized cardiorespiratory monitors at postnatal week 1 of life and weekly thereafter until 35 weeks' PMA or discharge; blood was collected for cytokines at postnatal weeks 1 and 3. NEC was diagnosed via Modified Bell's Staging Criteria.

RESULTS: HF-HRV was decreased at weeks 1 and 2 in neonates (47% females) who developed feeding intolerance or stage 2+ NEC. In addition, these neonates displayed elevated levels of IL-8 at week 1 and increased levels of IL-1β, IL-6, TNF-α, and IL-8 at week 3 of life. Low HF-HRV was associated with elevated IL-6 or IL-8 levels at weeks 1 and 3 of life. Logistic regression indicated that only HF-HRV was a significant predictor of feeding intolerance or NEC development.

IMPLICATIONS FOR PRACTICE AND RESEARCH: HRV is a promising noninvasive modality for NEC risk detection. The association of low HF-HRV with elevated proinflammatory cytokines provides evidence for a putative role of the vagal cholinergic pathway in NEC pathogenesis. Future studies should focus on application of these techniques to test clinical therapeutics.Video Abstract available at https://journals.lww.com/advancesinneonatalcare/Pages/videogallery.aspx?autoPlay=false&videoId=54.

Copyright © 2021 by The National Association of Neonatal Nurses.

Conflict of interest statement

K.K.D. and C.P. are inventors on a US patent that describes analytic methods used for heart rate variability to determine necrotizing enterocolitis risk. This patent is owned by The Pennsylvania State

References

  1. Arch Dis Child Fetal Neonatal Ed. 2007 Nov;92(6):F449-53 - PubMed
  2. Neurogastroenterol Motil. 2009 Jan;21(1):6-17 - PubMed
  3. BMC Res Notes. 2013 Dec 20;6:547 - PubMed
  4. Curr Opin Clin Nutr Metab Care. 2015 May;18(3):285-8 - PubMed
  5. Nature. 2002 Dec 19-26;420(6917):853-9 - PubMed
  6. J Pediatr. 2016 Jul;174:57-62 - PubMed
  7. Neurogastroenterol Motil. 2019 Mar;31(3):e13484 - PubMed
  8. PLoS One. 2013;8(3):e58720 - PubMed
  9. Adv Neonatal Care. 2012 Apr;12(2):77-87; quiz 88-9 - PubMed
  10. J Leukoc Biol. 2016 Jan;99(1):67-78 - PubMed
  11. Adv Neonatal Care. 2018 Feb;18(1):49-57 - PubMed
  12. J Clin Neonatol. 2014 Jan;3(1):1-9 - PubMed
  13. Front Psychol. 2017 Feb 20;8:213 - PubMed
  14. Mediators Inflamm. 2013;2013:434010 - PubMed
  15. Gastroenterology. 2017 Mar;152(4):730-744 - PubMed
  16. Pediatrics. 1993 Mar;91(3):617-23 - PubMed
  17. Front Neurosci. 2018 Feb 07;12:49 - PubMed
  18. Am J Perinatol. 2017 Nov;34(13):1286-1292 - PubMed
  19. J Perinat Neonatal Nurs. 2015 Oct-Dec;29(4):315-44; quiz E2 - PubMed
  20. Clin Perinatol. 2019 Mar;46(1):29-38 - PubMed
  21. Semin Perinatol. 2008 Apr;32(2):100-6 - PubMed
  22. Am J Surg. 2015 Oct;210(4):661-7 - PubMed
  23. Early Hum Dev. 2017 Feb;105:25-33 - PubMed
  24. Eur J Pharmacol. 2008 Apr 7;583(2-3):174-85 - PubMed
  25. J Pediatr. 2005 Oct;147(4):462-8 - PubMed
  26. Eur Heart J. 1996 Mar;17(3):354-81 - PubMed
  27. Nat Rev Gastroenterol Hepatol. 2016 Oct;13(10):590-600 - PubMed
  28. Pediatr Res. 2014 Jul;76(1):100-8 - PubMed
  29. J Perinatol. 2017 Jun;37(6):668-672 - PubMed
  30. Am J Perinatol. 2017 Dec;34(14):1389-1395 - PubMed
  31. Neurogastroenterol Motil. 2014 Jun;26(6):832-40 - PubMed
  32. Pediatr Res. 2017 Sep;82(3):438-443 - PubMed
  33. J Neonatal Nurs. 2017 Jun;23(3):134-141 - PubMed
  34. J Perinat Neonatal Nurs. 2015 Jan-Mar;29(1):51-9; quiz E2 - PubMed
  35. Natl Vital Stat Rep. 2019 Nov;68(13):1-47 - PubMed
  36. J Pediatr. 2018 Dec;203:62-67 - PubMed
  37. Pediatrics. 1995 Nov;96(5 Pt 1):918-22 - PubMed
  38. Am J Perinatol. 2014 Jun;31(6):489-96 - PubMed
  39. Pediatrics. 2012 Jun;129(6):1019-26 - PubMed
  40. BMC Pediatr. 2013 Sep 10;13:138 - PubMed
  41. Am J Perinatol. 2019 Apr;36(5):505-510 - PubMed
  42. BMC Pediatr. 2017 Apr 14;17(1):105 - PubMed
  43. Ann Surg. 1978 Jan;187(1):1-7 - PubMed
  44. Exp Biol Med (Maywood). 2020 Jan;245(2):85-95 - PubMed
  45. Am J Perinatol. 2018 Sep;35(11):1079-1086 - PubMed
  46. Early Hum Dev. 2013 Oct;89 Suppl 2:S13-20 - PubMed
  47. Curr Pediatr Rev. 2019;15(2):68-87 - PubMed
  48. Neurogastroenterol Motil. 2019 Nov;31(11):e13682 - PubMed
  49. Pediatr Crit Care Med. 2016 Apr;17(4):e165-76 - PubMed

Substances

MeSH terms

Publication Types

Grant support